Publicaciones
-
Mora J, Castañeda-Heredia A, Colombo MC, Gorostegui M, Fernando Gómez Muñoz, Mañe S, Santa-María López V, Garraus-Oneca M, Macias N, Pérez-Jaume S, Muñoz-Aznar O, Muñoz JP, Barber-Martínez de la Torre I and Suñol M.
Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma
Cancers . 13(6): 164. Nº de citas: 12
-
Mora J, Castañeda-Heredia A, Flores MA, Santa-María V, Garraus-Oneca M, Gorostegui M, Simao M, Pérez-Jaume S and Mañe S.
The Role of Autologous Stem-Cell Transplantation in High-Risk Neuroblastoma Consolidated by anti-GD2 Immunotherapy. Results of Two Consecutive Studies
Frontiers in Pharmacology . 11: 575009-575009. Nº de citas: 17
-
Inarejos E, Navallas M, Barber Martínez de la Torre I, Suñol M, Munuera-del Cerro JL, Torner F, Garraus-Oneca M and Navarro OM.
MRI of Rhabdomyosarcoma and Other Soft-Tissue Sarcomas in Children
RADIOGRAPHICS . 40(3): 791-814. Nº de citas: 59
